National Institute of General Medical Sciences
Overview
The National Institute of General Medical Sciences (NIGMS) is one of the National Institutes of Health (NIH) in the United States. It primarily supports basic biomedical research that is not targeted to specific diseases, aiming to increase the understanding of life processes and lay the foundation for advances in disease diagnosis, treatment, and prevention. The institute funds research in fields like cell biology, genetics, pharmacology, and computational biology. NIGMS also provides leadership in training the next generation of scientists and increasing the diversity of the scientific workforce. It supports thousands of investigators and research grants across the U.S.
Portfolio Companies
16
Website
nigms.nih.govInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Synvivia | Dec 2024 | Grant | Lead |
| Eclipsebio | Jul 2024 | Grant | Co-investor |
| Indee Labs | Sep 2023 | Grant | Co-investor |
| Alida Bio | May 2023 | Grant | Co-investor |
| GenNext Technologies | Apr 2023 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.